Cientifica Ltd., Sep 2007, Pages: 301
nanomaterials/technologies to enable better drugdelivery compounds (drugdelivery company) and companies that are using nano-enabled formulations to enhance drugdelivery (drug formulation company).
This report
Global Industry Analysts, Inc., Jan 2011, Pages: 378
This report analyzes the US market for Intranasal DrugDelivery in US$ Million by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual estimates
Global Industry Analysts, Inc., April 2010, Pages: 599
This report analyzes the worldwide markets for Pulmonary DrugDelivery Technologies in US$ Million by the following Product Segments: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for drugdelivery systems across more than 2000 cities. For the year reported, estimates are given for the latent
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for oral drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for intranasal drugdelivery applications across more than 2000 cities. For the year reported, estimates
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for injectable drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for pulmonary drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for pulmonary drugdelivery technologies across more than 2000 cities. For the year reported, estimates are given
Life Science Analytics, March 2011, Pages: 101
Aveva DrugDelivery Systems-Therapeutic Competitors ReportReport includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for drugdelivery systems across more than 2000 cities. For the year reported, estimates are given for the latent
Life Science Analytics, March 2011, Pages: 27
3M DrugDelivery Systems (a division of 3M Company NYSE : MMM)-Deals & Alliances ReportReport contains the company’s contact information, business summary, company details, tables, graphs
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for oral drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for injectable drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for pulmonary drugdelivery systems across more than 2000 cities. For the year reported, estimates are given
ICON Group International, Jan 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for intranasal drugdelivery applications across more than 2000 cities. For the year reported, estimates
ICON Group International, Jan 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for pulmonary drugdelivery technologies across more than 2000 cities. For the year reported, estimates are given
Jain PharmaBiotech, Feb 2012, Pages: 281
This report deals with transdermal drugdelivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal
CurrentPartnering, Nov 2010, Pages: 428
The DrugDelivery Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drugdelivery partnering agreements entered
Jain PharmaBiotech, Feb 2012, Pages: 639
is the author of 415 publications including 16 books (2 as editor) and 48 special reports, which have covered important areas in biotechnology, gene therapy and biopharmaceuticals. DrugDelivery in Cancer